SPECT imaging in cerebrovascular disease Measurement of regional cerebral blood flow (rCBF) Sensitive indicator of perfusion Diagnosis and prognosis of.

Slides:



Advertisements
Similar presentations
Transient Global Amnesia Allan B. Wolfson, MD University of Pittsburgh Department of Emergency Medicine.
Advertisements

Some Difficult Stroke Cases: What Would You Do?
TPA… SMART or not SMART? That is the Question. Sarah Parker, MD.
What is a Stroke? Lumen ventricle A stroke is an injury to the brain caused by interruption of its blood flow, or by bleeding into or around the brain.
Hemorrhagic Stroke Dr. Grant Stotts Director, Ottawa Stroke Program.
Alternate Level of Care, Neurology HS317b – Coding & Classification of Health Data.
Ischemic Stroke without Infarctions: Occlusion and stenosis of carotid arteries ASN Conference September 12 th, 2013.
Neuroradiology DR. Sharifa AL-Duraibi.
STROKESTROKESTROKESTROKE. Why Change? Improve Mortality Improve Mortality Devastating and Life Altering Devastating and Life Altering Cost expense of.
Anticoagulation in Acute Ischemic Stroke. TPA: Tissue Plasminogen Activator 1995: NINDS study of TPA administration Design: randomized, double blind placebo-controlled.
STROKE Dr Ubaid N P Community Medicine Pariyaram Medical College.
Dr Hussein Farghaly PSMMC Radionuclide Brain Imaging Lecture 3
Dr Hussein Farghaly PSMMC Radionuclide Brain Imaging Master Watermark Image:
Brain Single-Photon Emission CT With HMPAO and Safety of Thrombolytic Therapy in Acute Ischemic Stroke Proceedings of the Meeting of the SPECT Safe Thrombolysis.
STROKE. Vascular System Reminder: All brain function is dependent on oxygen. There are two main arterial supplies to the brain: –Carotid Arteries –Basilar.
Cerebral Vascular Disease
Vascular Diseases Re-written by: Daniel Habashi Seminar by: Dr. Jezewski.
Diagnostic Stress Testing
Cerebrovascular diseases. Vascular occlusive diseases (ischemic stroke) Intracerebral hemorrhage (hemorrhagic stroke)
Stroke: An Acute and Treatable Condition Thomas G. Bowers, Ph.D.
Consultant Neurologist,
The Nature of Disease.
Dr Kneale Metcalf Stroke Physician (NNUHFT)
Jalal Jalal Shokouhi – MD Editor in Chief of Iranian Society of Radiology
IN THE NAME OF ALLAH THE MOST MERCIFUL, THE MOST KIND “Blessed is He in Whose hand is the Sovereignty, and He is Able to do all things Who hath created.
Morning Report August 7, 2012 Good Morning. Chorea **Show video**
The Transition to What you need to know for Neurology Date | Presenter Information.
Aim To determine the effects of a Coversyl- based blood pressure lowering regimen on the risk of recurrent stroke among patients with a history of stroke.
Brain Attacks CVA Add Corporate Logo Here To insert your company logo on this slide From the Insert Menu Select “Picture” Locate your logo file Click OK.
Dr Hussein Farghaly PSMMC Radionuclide Brain Imaging Master Watermark Image:
Stroke Damrongsak Bulyalert, M.D., Ph.D.
Treatment of Ischaemic Stroke The American Heart Association American Stroke Association Guidelines Stroke. 2007;38:
Delayed Posttraumatic Hemorrhage From (Stroke. 1995;26: ) © 1995 American Heart Association, Inc. Present by R2 Meng-Ting Wu.
Subarachnoid Hemorrhage Nina T. Gentile, MD Associate Professor Division of Emergency Medicine Temple University School of Medicine Philadelphia, PA.
The Pathophysiology of Ischemic Injury Neurology Course 4th Year.
Subarachnoid Hemorrhage. Etiology Spontaneous (primary) subarachnoid hemorrhage usually results from ruptured aneurysms. A congenital intracranial saccular.
Cerebrovascular diseases. Vascular occlusive diseases (ischemic stroke) Intracerebral hemorrhage (hemorrhagic stroke)
Chapter 31 Stroke. © 2005 by Thomson Delmar Learning,a part of The Thomson Corporation. All Rights Reserved 2 Overview  Pathophysiology  Types of Stroke.
Intracerebral Hemorrhage
Cerebrovascular diseases
1 Shock. 2 Shock refers to an abnormality of the circulatory system in which there is inadequate tissue perfusion due to a relatively or absolutely inadequate.
Dr. Meg-angela Christi M. Amores
Central Nervous System
Cerebrovascular disease Dr.Nathasha Luke Epidemiology 3rd leading cause of death and disability in the world 3rd leading cause of death and disability.
Diseases and Disorders of the Nervous System. schizophrenia Characterized by psychotic episodes involving hallucinations & delusions Genetic & environmental.
Rikki Weems, PGY III August 20, 2015
New ways of imaging Stroke/TIA Dr Suzanne O’Leary Neuroradiology SpR Frenchay Hospital.
Chapter 35 Stroke. Stroke: occurs when blood flow to the brain is interrupted by a clot in a artery or other vessel. When this occur brain cells begin.
Abstract No: eEdE-103 Submission Number: Disclosure There is no disclosure.
S TROKE M ANAGEMENT A CCORDING TO B EST P RACTICE ……..it matters…….. 1.
Stroke Kennedy Miller. Causes: A stroke may be caused by a blocked artery (ischemic stroke) or the leaking or bursting of a blood vessel (hemorrhagic.
Copyright © 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved. (Relates to Chapter 67, “Nursing Management: Shock, Systemic.
CVA, Vascular and Other Neurological Problems
Total Occlusion Study of Canada (TOSCA-2) Trial
Methodist LeBonheur Healthcare
Evidence-Base Medicine
Cerebrovascular Disorders
by: Prof.Dr. Hosna Moustafa Cairo University, Egypt
CASES 7-11.
Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) and Review of Literature Zebin Xiao Department of.
Brain Scintigraphy.
Stroke Niazy B Hussam.
Epilepsy in Diagnostic Imaging
Strokes.
Guidelines for Urgent Management of Stroke in Children
MRI Brain Evaluation of brain diseases Stroke
Cerebrovascular disease
Hypertension and Cerebrovascular Dysfunction
Presentation transcript:

SPECT imaging in cerebrovascular disease Measurement of regional cerebral blood flow (rCBF) Sensitive indicator of perfusion Diagnosis and prognosis of cerebro- vascular disease Tc-99m HMPAO brain SPECT

SPECT perfusion image Acute brain ischemia Perfusion defects after resolution of TIA Cerebral infarction Delayed ischemic deficits after SAH Determine pathophysiological mechanisms of stroke Monitor medical and surgical therapies

Normal tracer uptake Symmetric distribution Higher radioactivity: gray matter, basal ganglion, occipital cortex, cerebellum Lower radioactivity: white matter, ventricles

Abnormal tracer uptake Absent infarction, trauma, surgical resection Reduced ischemia, dementia, depression, seizure(interictal) Increased luxury perfusion, seizure(ictal)

Stroke 1 SPECT: superior to CT/MRI in detecting cerebral ischemia — earlier & larger rCBF imaging: effective in acute phase, less sensitive in the subacute phase -8h: SPECT-80%; CT-20% -72h: SPECT=CT/MRI

Stroke 2 False negative: lacunar infarctions, luxury perfusion(5~20 days) Crossed-cerebellar diaschisis: continues even during luxury perfusion Classifying stroke subtypes for treatment, recurrence, recovery and mortality

Cerebrovascular reserve 1 Increase the sensitivity of detecting perfusion failure Assess the need for acute interventions following stroke or the risk status for secondary strokes Useful in detecting ischemic sequelae in TIA, stroke, AVM, SAH p ’ t

Cerebrovascular reserve 2 Brain stress test: vasodilatory response to CO 2 or acetazolamide --compare resting images and vasodilated images (20~30min after acetazolamide injection) --diseased or at-risk areas show little or no response

Prognostication SPECT/CT volume defect sizes — larger ratios with better outcomes Flow index, density of counts/volume of defect on SPECT correlates clinical recovery at 1 month IMP uptake delayed(4h)/early(<1h) — larger with more viable brain tissue and better clinical outcomes

Transient Ischemic Attacks (TIA) Severity of persistent hypoperfusion Response of an ischemic area to medical or surgical intervention Identify p ’ t at high risk for early stroke following a TIA (persistent reduction in rCBF of >30% with high risk of subsequent infarction) Sensitivity declines with time, (24h — 60%, 1wk — 40%) can be enhanced by acetazolamide stress test

Monitoring therapies Determine pathophysiology after successful therapy In thrombolytic and anticoagulant treatments, changes in artery patency and recanalization can be evaluated.

Subarachnoid hemorrhage (SAH) Provide early evidence of cerebral ischemia due to vasospasm after SAH Vasospasm: decrease rCBF, increase cerebral blood volume Delayed cerebral ischemia with vasospasm — factors of recurrent hemorrhage in the morbidity or mortality of SAH

Arteriovenous malformation (AVM) 1 Complications Intracerebral/intraventricular bleeding Seizure Intracerebral steal due to AV shunting — produce ischemia Cerebrovascular reserve is prognostic for postoperative outcome

Arteriovenous malformation (AVM) 2 Reserve categorization: Normal Increased (pathological vasodilatation) hyper-responsiveness to acetazolamide in regions of steal in the resting state Failed (no vasodilatory reserve in steal areas)

Others Vascular disease — migraine, vascular dementia, transient global amnesia Alzheimer ’ s disease Head injury Epilepsy Brain death